335 related articles for article (PubMed ID: 12162685)
1. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
[TBL] [Abstract][Full Text] [Related]
2. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
[TBL] [Abstract][Full Text] [Related]
3. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
[TBL] [Abstract][Full Text] [Related]
4. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
6. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
9. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
10. Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis.
Baldus SE; Zirbes TK; Thiele J; Eming SA; Henz BM; Hartmann K
Haematologica; 2004 Dec; 89(12):1525-7. PubMed ID: 15590405
[TBL] [Abstract][Full Text] [Related]
11. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
13. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
14. [Acute myelomonocytic leukemia with mastocytosis in bone marrow].
Natori H; Nakamura E; Tanaka K; Naito K; Egami K; Honda J; Osabe S; Imamura Y; Natori K; Yasuda K
Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687
[TBL] [Abstract][Full Text] [Related]
15. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
Olafsson JH
Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
[TBL] [Abstract][Full Text] [Related]
17. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
Huttunen M; Naukkarinen A; Horsmanheimo M; Harvima IT
Arch Dermatol Res; 2002 Oct; 294(7):324-30. PubMed ID: 12373338
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
[TBL] [Abstract][Full Text] [Related]
19. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of systemic mastocytosis using a semiquantitative method of assessing the mast cell population].
Tomilov AF; Podivilova TN
Ter Arkh; 1990; 62(4):108-11. PubMed ID: 2392747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
